Puti profilaktiki sakharnogo diabeta tipa 2

Puti profilaktiki sakharnogo diabeta tipa 2

Сахарный диабет типа 2 (СД 2) представляет собой одно из наиболее быстро распространяющихся хронических заболеваний, охватывающее население всех, без исключения, стран мира. Скорость разрастания этой ?метаболической эпидемии? находится в прямой зависимости от внедрения в повседневную жизнь современн...

Full description

Bibliographic Details
Main Authors:	Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2002-12-01
Series:	Сахарный диабет
Subjects:	инсулинорезистентность диетотерапия скрининг сердечно-сосудистых осложнений экономическая эффективность
Online Access:	https://www.dia-endojournals.ru/jour/article/view/7490

Similar Items

Primenenie podslastiteleyv dietoterapii sakharnogo diabeta
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2006-09-01)

Insulinorezistentnost' v patogeneze sakharnogo diabeta 2 tipa
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2001-03-01)

Subclinical depression and anxiety as an additional risk factor for cardiovascular events in low- and moderate-risk patients: data from 10-year follow-up
by: M. D. Smirnova, et al.
Published: (2021-07-01)

Osnovnye printsipy terapii sakharnogo diabeta 2 tipa
by: Ivan Ivanovich Dedov, et al.
Published: (1999-03-01)

Rasprostranennost' sakharnogo diabeta 2 tipa (po dannym skrininga)
by: N S Shishkina, et al.
Published: (2005-06-01)

O kombinirovannoy terapii sakharnogo diabeta tipa 2
by: Ashot Musaelovich Mkrtumyan
Published: (2002-09-01)

Geneticheskie aspekty sakharnogo diabeta
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2000-03-01)

Antihypertensive therapy effectiveness in patients with arterial hypertension and varying risk of cardiovascular events
by: I. E. Chazova, et al.
Published: (2008-04-01)

HEALTH EFFECTS OF HOT SUMMER WEATHER IN PATIENTS WITH INTERMEDIATE AND HIGH CARDIOVASCULAR RISK
by: M. D. Smirnova, et al.
Published: (2013-08-01)

K voprosu o profilaktike sakharnogo diabeta tipa 2
by: Ashot Musaelovich Mkrtumyan
Published: (2002-09-01)

Avandiya ostaetsya odnim iz preparatov vybora v lechenii sakharnogo diabeta 2 tipa
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2008-03-01)

Programma skrininga sakharnogo diabeta 2 tipa v Sankt-Peterburge
by: Irina Al'bertovna Karpova, et al.
Published: (2001-12-01)

Insulinorezistentnost' i ee znachenie v patogeneze narusheniy uglevodnogo obmena i sakharnogo diabeta tipa 2
by: Mikhail Ivanovich Balabolkin
Published: (2002-03-01)

Perspektivy lecheniya i profilaktiki sakharnogo diabeta 1 tipa
by: Olga Mikhailovna Smirnova
Published: (2000-06-01)

Uric acid – the key component of “cardio-reno-metabolic continuum”
by: Zh. D. Kobalava, et al.
Published: (2008-08-01)

Poslednie dostizheniya i perspektivy profilaktiki sakharnogo diabeta 1 tipa
by: Tamara Leonidovna Kuraeva, et al.
Published: (2000-03-01)

Lechenie sakharnogo diabeta tipa 1 na sovremennom etape
by: Ivan Ivanovich Dedov, et al.
Published: (2002-12-01)

Akarboza v profilaktike sakharnogo diabeta tipa 2
by: Marina Vladimirovna Shestakova, et al.
Published: (2003-06-01)

Profilaktika pozdnikh oslozhneniy sakharnogo diabeta u detey i podrostkov. Puti optimizatsii dispansernoy sluzhby
by: E P Kasatkina, et al.
Published: (1999-03-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure
by: I. E. Chazova
Published: (2008-04-01)

Current approaches to the selection of acetylsalicylic acid dosage forms in cardiology
by: S. R. Gilyarevskiy, et al.
Published: (2022-06-01)

Prospektivnoe nablyudenie za det'mi s sakharnym diabetom 1 tipa v Moskve
by: Ivan Ivanovich Dedov, et al.
Published: (1999-09-01)

Rezul'taty skrininga oslozhneniy sakharnogo diabeta v Tyumenskoy oblasti
by: Lyudmila Alexandrovna Suplotova, et al.
Published: (2005-06-01)

CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE
by: A. V. Kontsevaya, et al.
Published: (2016-01-01)

ПРОФИЛАКТИКА И ВМЕШАТЕЛЬСТВО – ПОЛИТИКА ЗДРАВООХРАНЕНИЯ
Published: (2008-10-01)

METABOLIC EFFECTS OF ADIPONECTINE
by: E. V. Mitroshina, et al.
Published: (2014-12-01)

Algorithm for predicting cardiovascular events in low/moderate risk patients using traditional and new factors: data from 10-year follow-up study
by: M. D. Smirnova, et al.
Published: (2021-10-01)

Gosudarstvennyy registr sakharnogo diabeta: epidemiologicheskaya kharakteristika insulinnezavisimogo sakharnogo diabeta
by: Yury Ivanovich Suntsov, et al.
Published: (1998-03-01)

Проблема назначения статинов больным с сердечно-сосудистыми заболеваниями и сопутствующими болезнями печени. Что препятствует преодолению статинофобии?
Published: (2016-06-01)

Проблема назначения статинов больным с сердечно-сосудистыми заболеваниями и сопутствующими болезнями печени. Что препятствует преодолению статинофобии?
Published: (2016-06-01)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Uchastie E-selektina v razvitii mikrososudistykh oslozhneniy sakharnogo diabeta 1 tipa
by: T V Kochemasova, et al.
Published: (2002-03-01)

Rezul'taty skrininga sakharnogo diabeta u zhiteley g. Abakana (Respublika Khakasiya)
by: S A Dogadin, et al.
Published: (2008-06-01)

SOCIO-ECONOMIC EFFECTIVENESS OF HEALTH SCREENING ACTIVITY IN 2013 IN RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2014-06-01)

MORBIDITY AND MORTALITY FROM CARDIOVASCULAR DISEASES ACCORDING TO THE SEA-LEVEL RELATED ALTITUDE OF A REGION
by: A. A. Dotdaeva, et al.
Published: (2014-12-01)

Рекомендации по совместному назначению статинов и урсодезоксихолевой кислоты пациентам с высоким риском сердечно-сосудистых осложнений и сопутствующей неалкогольной жировой болезнью печени: проблемы практического применения
Published: (2017-03-01)

Рекомендации по совместному назначению статинов и урсодезоксихолевой кислоты пациентам с высоким риском сердечно-сосудистых осложнений и сопутствующей неалкогольной жировой болезнью печени: проблемы практического применения
Published: (2017-03-01)

Epidemiologicheskie issledovaniya sakharnogo diabeta tipa 1 v detskom vozraste v Evrope
by: Ivan Ivanovich Dedov, et al.
Published: (2003-03-01)

O semeynoy forme sakharnogo diabeta 2 tipa u molodykh (MODY)
by: Tatiana Vasil'evna Nikonova, et al.
Published: (1999-12-01)